NCT02244268View on ClinicalTrials.gov

Study to Evaluate the Effect of ALNA® (Tamsulosin) on the Primary Symptoms of Benign Prostatic Hyperplasia

CompletedOBSERVATIONAL
Enrollment

3,629

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

December 31, 2001

Conditions
Prostatic Hyperplasia
Interventions
DRUG

ALNA®

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY